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Research brief

FINDINGS
FROM LANDSCAPE
ANALYSIS IN BANGLADESH ON
PRE-ECLAMPSIA/ECLAMPSIA
Despite global efforts to reduce preventable
maternal and neonatal mortality, between
5,000 and 6,000 maternal deaths occur
each year in Bangladesh. Pre-eclampsia and
eclampsia (PE/E) cause 20% of these deaths.
Maternal and newborn deaths due to PE/E are preventable, yet
in Bangladesh PE/E is the second most common direct cause of
maternal mortality, after post-partum hemorrhage (PPH).

APRIL 2016

To appreciate the enormity of this problem, at national and
district levels, in 2015 the Population Council conducted a
landscape analysis in four districts to:
•

Understand the volume of PE/E research in the last 15
years;

•

Know the degree of programmatic and policy support for
PE/E prevention and treatment;

•

Analyze the gaps in providers’ knowledge and competence
for preventing, detecting, and managing PE/E;

•

Determine primary health care (PHC) facilities’ capacities to
manage PE/E;

•

Assess community awareness, beliefs, and experiences
around PE/E; and

•

Determine priority areas for PE/E research and
programmatic interventions.

PE/E IN BRIEF
• Pre-eclampsia is a condition
in pregnant women marked by an
increase in blood pressure and
protein in urine after 20 weeks
gestation.
• Providing high quality antenatal care
improves the prevention and early
detection of pre-eclampsia and can
prevent its progression to eclampsia.
• Eclampsia is a life-threatening
condition characterized by
convulsions in women with PE.
• Women in developing countries are
300 times more likely to die from
eclampsia than women in developed
countries.
• Prescribing low-dose aspirin and
calcium to at-risk women can prevent
pre-eclampsia and eclampsia.
• Pre-eclampsia and eclampsia can
be managed by administering antihypertensive drugs and magnesium
sulphate (MgSO4).
• MgSO4 is the safest and most
effective treatment for severe PE/E,
and is one of 13 UN Life-Saving
Commodities for Women and
Children.

The Ending Eclampsia project seeks to expand access
to proven, underutilized interventions and commodities
for the prevention, early detection, and treatment of preeclampsia and eclampsia and strengthen global partnerships.

• PE/E and other hypertensive
disorders in pregnancy increase the
risk of pre-term births, which can
lead to low birth weight, anemia, and
stunting.

For more information, visit endingeclampsia.org.

• Improved prevention, increased
detection, and effective treatment
of PE/E can prevent unnecessary
maternal and newborn deaths.
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NATIONAL POLICY
AWARENESS

SERVICE PROVIDER
KNOWLEDGE AND SKILLS

The Bangladesh government’s policy on PE/E falls
under the broader realm of maternal health, with
Standard Operating Procedures specifying prevention
and management of PE/E at secondary and tertiary
facilities. The government has yet to formalize any
policy on PE/E prevention and management at primary
facilities. A protocol has been developed, tested, and
approved for implementation in the field, but it has not
been widely circulated.

Researchers interviewed 289 service providers from 134
facilities, 79 doctors and 210 other service providers.
Exploring their knowledge, attitudes, and practices
regarding maternal health, but specifically PE/E, was
vital for understanding the gaps that need attention.

There is confusion among policy makers and program
managers about PE/E prevention and treatment
policies. A majority of them informed Council
researchers they not aware of any policy addressing
PE/E, nor do they have copies of it, or written
instructions.
In fact, only 27% of doctors and 3% of other providers,
which include nurses/midwives, family welfare visitors
(FWVs), and sub-assistant community medical officers
(SACMOs), know of any such guidelines.
One respondent said:

“I don’t know about the
government policy. There might
be one. I cannot tell you about the
policy, as I didn’t get it yet. I didn’t
get the policy in my hand, so I don’t
know about where the policy is
being implemented. There is no
implementation policy in my district
or upazilas.”
Policy maker and program
manager, Ministry of Health and
Family Welfare
All district hospitals reported availability of guidelines
or protocols, but only 50% of maternal and child welfare
centers (MCWCs) and 36% of upazila health complexes
(UHCs) have the same. As expected, no union health
and family welfare center (UH&FWC) has any guidelines
or protocols for diagnosing and managing PE/E.
Researchers found a similar situation for guidelines
or protocols on the administration of MgSO4; no
written guidelines or protocol exists in any center.
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Results showed that 84% of doctors and 79% of
other service providers were able to correctly define
hypertension as systolic blood pressure of ≥140 mmHg
and/or diastolic blood pressure of ≥90 mmHg. Despite
this, 17% of doctors and 22% of service providers
are confused about the definition of hypertension.
Researchers asked service providers to identify
signs and symptoms of pre-eclampsia, severe preeclampsia and eclampsia. Results showed that doctors
know, and other service providers had reasonably
good knowledge, of the signs and symptoms.
Figure 1 shows correct responses from providers.

FIGURE 1. KNOWLEDGE OF SIGNS AND
SYMPTOMS OF PRE-ECLAMPSIA (%)

To prevent pre-eclampsia from progressing to
eclampsia, service providers must know which
antihypertensive drugs to use and when to initiate
treatment. When a patient experiences convulsions
due to eclampsia, providers should also know which
anticonvulsants, such as MgSO4, to administer and
how to monitor, identify, and prescribe calcium
gluconate for any MgSO4 toxicity, if necessary.
Researchers asked providers about commonly used
antihypertensive drugs for managing mild to moderate
hypertension and severe hypertension in pregnancy, as
well as when to initiate treatment for these conditions.
The drug of choice is labetalol, but it is expensive
and not widely available. Methyldopa or nifedipine

are the next best drugs for this use, and hydralazine
is best for severe hypertension in pregnancy. Only
77% of doctors and 19% of other service providers
mentioned methyldopa or nifedipine as their drugs of
choice for managing mild to moderate hypertension
in pregnancy. For severe hypertension, 9% of doctors,
and no other service providers, mentioned hydralazine.
Only 19% percent of doctors and 9% of other service
providers correctly knew when to initiate hydralazine.

FIGURE 2. SERVICE PROVIDER KNOWLEDGE
OF PROPHYLACTIC DRUG USE FOR PE/E
INTERVENTION (%)

central level regularly or purchase it from local markets.
The remaining 45% said patients purchase it from
markets when needed.
Researchers asked informants from facilities if service
providers had the necessary skills for providing
Emergency Obstetric and Neonatal Care, which include
the capacity to administer prenatal antibiotics, oxytocin,
and anticonvulsants, as well as blood transfusions,
caesarian sections, and neonatal resuscitation.
Researchers also asked if these procedures occurred
within the last three months. Findings suggest not all
elements are available in all secondary facilities, and
many did not occur in the last three months.
All facility informants were asked if they have certain
regular and emergency response materials in their
facilitiy, particularly those for PE/E services. Almost all
secondary facilities reported regular and emergency
response materials.

During antenatal care (ANC) consultations, only 1.87%
of providers looked for PE risk factors. About 4%
advised women of symptoms for impending eclampsia,
and 8% of secondary facility providers and 1% from
primary facilities described pre-eclampsia detection,
which explains the low detection of PE/E patients
by primary and secondary facility providers during
ANC and postnatal care (PNC) consultations. This
supports evidence that shows service providers’ lack
of knowledge, skills, low confidence, poor logistical
support, and reluctance among lower cadre providers.

FACILITY CAPACITY AND
PREPAREDNESS

Primary facilities, however, are not designed to
provide emergency care, and some facilities have the
materials in variable quantities. Thirteen centers have
20 milliliter syringes, none had 6mg betamethasone/
dexamethasone for premature respiratory distress
syndrome (PRDS), and 15 primary facilities had none
of the regular and emergency response materials.
Interestingly, 61% and 86% of primary facilities
had misoprostol for PPH prevention and neonatal
resuscitation kits, respectively.
See Figure 3 for details on the availability of emergency
response at facilities.

FIGURE 3. AVAILABILITY OF EMERGENCY
RESPONSE SUPPLIES AT FACILITIES

For effective and timely treatement, it is essential that
certain equipment and commodities are available at
facilities. MgSO4 was found in four secondary facilities,
but in no UH&FWCs. Four secondary facilities reported
its regular use, while seven reported occasional use.
Calcium gluconate for managing MgSO4 toxicity was
found in only one secondary facility, but not in any
primary facilities.
It is important to note that 75% of MCWCs and 45% of
secondary facilities never used MgSO4. Those who do
administer MgSO4 use it in varying concentrations, from
20% solution, to 4% water/volume, to 50% solution,
while some did not know which concentration they use.
Of the facilities that use MgSO4, 55% get it from the
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COMMUNITY KNOWLEDGE
AND PERCEPTIONS
To assess community PE/E awareness, beliefs,
and experiences, and strategies for seeking care,
researchers investigated community perspectives in
male and female focus group discussions and in-depth
interviews with PE/E survivors and their families.
Despite some similarities, there were major disparities
between female and male informants about the serious
problems women suffer during and after delivery.
Female participants said the most serious problems
during pregnancy and immediately following childbirth
are excessive bleeding, convulsion, anemia, abdominal
pain, physical weakness, malnutrition, retained
placenta, ruptured uterus, and fetal presentation other
than head first.
Male informants reported anemia, physical weakness,
leucorrhea (discharge), loss of appetite, headache,
edema, retained placenta, and bleeding from the vagina
as the most serious problems. Both men and women
report that mothers-in-law are best equipped to make
decisions when a women experiences complications.

“These are women’s problems
during pregnancy and after
delivery. My mother also passed
through these. So, I don’t want to
interfere with women’s problems
and step in. My mother and
grandmother might be the right
persons to decide.” Male, FGD
While one female respondent said:

“The mothers of our community
think these are general problems
during pregnancy and delivery and
they also passed through these. So,
they don’t give much importance
on the problems, rather suggest
some spiritual and common sense
remedies.” Female, FGD
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RECOMMENDATIONS
•

Develop policy for primary and secondary facilities
to implement uniform clinical practice of PE/E
prevention and management;

•

Trainings for all health providers according to new
policy;

•

Distribute official policy guidelines throughout the
health system;

•

Review and revise curricula for nurses, midwives,
FWVs, SACMOs, and paramedics;

•

All levels of service providers should be properly
trained on broader maternal and newborn
health issues, particularly PE/E, to build their
confidence and skills for its prevention, detection,
and management. Training should also include
emergency management of premature births and
referrals to higher level facilities;

•

ANC, delivery, and PNC service providers should
screen every patient for increased blood pressure
and assess PE/E risk;

•

PE/E training for field workers, supervisors, and
program managers should create more awareness
within communities about the importance of ANC
and PNC care, and signs and symptoms of PE/E;

•

Essential emergency materials need to be available
in all facilities, with regular monitoring from district
program managers; and

•

Referral system strengthening.
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